epoetin alfa (recombinant human erythropoietin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for epoetin alfa (recombinant human erythropoietin), covering 2011-06-16 to 2011-06-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients [NA]